“Probable Reversible Encephalopathy With Ceftazidime Avibactam and Aztreonam: A Case Report”. Asian Journal of Pharmaceutical and Health Sciences, vol. 16, no. 2, June 2026, pp. 3283-7, https://doi.org/10.5530/ajphs.2026.16.94.